Contrast Media Market Outlook, Key Players, End User, Demand and Analysis Growth Trends by 2030
Contrast
media substances or agents assist in increasing the contrast of structures or
fluids of the body during medical imaging. They enhance the visibility of blood
vessels. The global Contrast Media Market is anticipated to grow at a CAGR of
6.3% during the assessment period of 2022-2030, asserts Market Research Future
(MRFR) in a detailed research report.
Rising
prevalence of various chronic diseases, increasing burden of cancer, and hike
in mortality rates on a global scale which generates high demand for diagnosis
and image-guided procedures. Contrast media finds application in diverse
modalities such as ultrasound, MRI scans, x-rays and in cath lab procedures.
Unlike
x-rays, contrast agents are associated with fewer adverse drug reactions. The
favorable safety profile of contrast media makes them the preferred choice for
medical imaging purposes as they can even be used to diagnose pregnant women
without any side effects.
Competitive Landscape
The global Contrast Media Market Players such as CMC Contrast AB (Sweden),
Bracco Diagnostic Inc. (Italy), Guerbet (Japan), Covidien (Ireland), Subhra
Pharma Private Limited (India), Bayer Healthcare Pharmaceuticals (Germany),
Daiichi (Japan), GE Healthcare (US), Targeson (US), NanoScan Imaging (US), AMAG
Pharmaceuticals (US), Bracco Imaging S.p.A. (Italy), nanoPET Pharma GmbH
(Germany), Guerbet Group (France), Lantheus Medical Imaging (U.S.), Medrad Inc
(US), and Mallinckrodt Pharmaceuticals (UK).
Segmentation
The global
contrast media market has been segmented based on type, procedure, application,
and route of administration.
·
By type, the
market has been segmented into intravenous contrast materials, iodine-based and
other.
·
By procedure,
the market has been segmented into X-ray, computed tomography, magnetic resonance imaging, ultrasound and other.
·
By application,
the market has been segmented into cardiovascular disorders, oncology,
nephrological disorders.
·
By route of administration, the market has been segmented into rectal, oral, injectable and other.
Regional Analysis
North
America, Europe, Asia Pacific, and the Middle East & Africa are the key
markets for contrast media. North America dominates the global contrast media
market followed by Europe. High healthcare expenditure, usage of
technologically advanced medical imaging techniques and the presence of eminent
players in the region supports the growth of the market in North America.
The Europe
market is driven by high investment in R&D, high government support and
concentration of key players in countries such as France, Germany, Italy, and
Sweden.
Asia
Pacific is poised be the fastest growing market for contrast media due to
increasing awareness in the region, the presence of a substantial patient
population and high investment in the development of healthcare infrastructure.
Industry Updates
- In November 2018, the U.S. Food and Drug
Administration (FDA) approved the clinical use of a magnetic resonance
imaging (MRI) scanner which allows spotting pituitary tumors in crushing's
patients. The new ultra-high field 7T Terra MRI scanner allows more
reliable images of the brain and facilitates identification of very small
tumors which standard MRI fails to spot.
- In October 2018, Israeli startup iNNOGING
innovated breakthrough in sonography technology. The innovation will
enable physicians to manipulate captured ultrasound video and allow
virtual dynamic examination by conversion of the video clip into a 3D
model without the presence of the patient.
About US:
Market Research Future (MRFR) enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private
Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment